Economic Burden and Costs of Chronic Migraine

Chronic Daily Headache (SJ Wang, Section Editor)

DOI: 10.1007/s11916-013-0385-0

Cite this article as:
Lanteri-Minet, M. Curr Pain Headache Rep (2014) 18: 385. doi:10.1007/s11916-013-0385-0
Part of the following topical collections:
  1. Topical Collection on Chronic Daily Headache


Chronic migraine (CM) is a subtype of migraine broadly defined by the presence of headache at least 15 days per month. Emerging evidence suggests that CM and episodic migraine (EM) differ not only in headache frequency, but that they are distinct clinical entities. Because individuals with CM are more disabled, they demonstrate higher societal burden than those with EM. There have been three important surveys published within the last five years that have focused on the societal burden associated with CM. The first is the American Migraine Prevalence and Prevention (AMPP) study, a longitudinal population-based survey performed in the U.S. The second, the International Burden Migraine Study (IBMS), is a Web-based survey conducted in North America, Western Europe, Asia/Pacific, and Brazil. The third is a clinic-based survey performed in Taiwan. This review discusses results of these studies with regard to healthcare resource use (and related direct costs) and loss of productivity (and related indirect costs) from the perspective of cost-effectiveness of new therapeutic approaches to CM.


Chronic migraine Episodic migraine Epidemiology Burden Health resource use Lost productivity time MIDAS Direct costs Indirect costs Cost-effectiveness 

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Département d’Evaluation et Traitement de la Douleur, Pôle Neurosciences Cliniques CHU de NiceHôpital de CimiezNiceFrance

Personalised recommendations